GLAXOSMITHKLINE PLC's ticker is GSK and the CUSIP is 37733W105. A total of 35 filers reported holding GLAXOSMITHKLINE PLC in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $2,687,000 | -12.8% | 61,732 | -12.8% | 0.79% | +30.4% |
| Q1 2022 | $3,082,000 | +7.2% | 70,762 | +8.6% | 0.61% | +0.5% |
| Q4 2021 | $2,874,000 | +15.8% | 65,177 | +0.4% | 0.60% | +16.3% |
| Q3 2021 | $2,481,000 | +4.8% | 64,931 | +9.2% | 0.52% | +7.4% |
| Q2 2021 | $2,367,000 | +24.1% | 59,441 | +11.2% | 0.48% | +4.1% |
| Q1 2021 | $1,907,000 | +23.0% | 53,436 | +26.8% | 0.46% | +13.1% |
| Q4 2020 | $1,551,000 | -4.4% | 42,143 | -6.0% | 0.41% | -11.0% |
| Q3 2020 | $1,622,000 | -12.2% | 44,830 | -1.0% | 0.46% | -27.6% |
| Q2 2020 | $1,848,000 | -7.8% | 45,293 | -3.6% | 0.64% | -24.7% |
| Q1 2020 | $2,004,000 | +12.8% | 47,001 | +24.4% | 0.85% | +37.1% |
| Q4 2019 | $1,776,000 | – | 37,796 | – | 0.62% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sio Capital Management, LLC | 325,823 | $11,557,000 | 6.52% |
| KAHN BROTHERS GROUP INC | 1,139,163 | $40,406,111,000 | 6.35% |
| Chubb Ltd | 400,000 | $14,188,000 | 6.18% |
| Healthcare Value Capital, LLC | 50,000 | $1,774,000 | 5.40% |
| CLARK ESTATES INC/NY | 650,000 | $23,056,000 | 3.81% |
| PVG ASSET MANAGEMENT CORP | 220,450 | $7,819,361,000 | 3.57% |
| Martin Capital Partners, LLC | 88,195 | $3,128,000 | 3.25% |
| Camber Capital Management LP | 1,500,000 | $53,205,000 | 2.60% |
| EQUITY INVESTMENT CORP | 2,090,120 | $74,137,000 | 2.47% |
| Keystone Financial Planning, Inc. | 129,102 | $4,579,000 | 2.44% |